Joel Isohookana and his colleagues' results show that expression of Keap1, main mediating degradation of Nrf2, was a significant prognostic factor in pancreatic adenocarcinomas 24. This evidence concerns the gene NFE2L2 and pancreatic adenocarcinoma.